Fungal Keratitis Treatment Market Size Projections Exhibit a CAGR of 5.1%, Likely to Attain a Value of USD 1.48 Billion by 2033 [Yahoo! Finance]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
North America emerged as the most significant global fungal keratitis treatment market, with a 42.3% market revenue share in 2023. Newark, April 17, 2024 (GLOBE NEWSWIRE) -- The Brainy Insights estimates that the USD 0.90 billion fungal keratitis treatment market will reach USD 1.48 billion by 2033. A fungal infection of the cornea, known as fungal keratitis, can result in blindness. Blurred vision and a red, hurting eye are the usual symptoms. It is an infectious process of the cornea brought on by any of the many pathogenic fungi that can penetrate the eye's surface. It is usually a slow-moving, unforgiving illness that needs to be distinguished from other corneal disorders that present similarly, particularly its bacterial counterpart, which causes most microbial corneal infections. The two most frequent species of Aspergillus that cause fungal keratitis are A. fumigatus and A. flavus. Additionally, the March 2021 MDPI article states that fungal keratitis, caused by filamentous y
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Bausch Health Companies Inc. (NYSE: BHC) had its price target raised by analysts at Piper Sandler from $7.00 to $9.00. They now have a "neutral" rating on the stock.MarketBeat
- Acute Repetitive Seizures Market Predicted to Reach USD 7.94 Billion By 2032, With a Growth of 11.9% CAGR: Polaris Market Research [Yahoo! Finance]Yahoo! Finance
- Bausch Health Companies Inc. (NYSE: BHC) had its price target lowered by analysts at Royal Bank of Canada from $12.00 to $11.00. They now have a "sector perform" rating on the stock.MarketBeat
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business Awards [Yahoo! Finance]Yahoo! Finance
- Makers Nutrition Founder and CEO Jason Provenzano Stands Triumphant in the 2024 TITAN Business AwardsPR Web
BHC
Earnings
- 2/22/24 - Miss
BHC
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEFA14A
- 4/4/24 - Form DEF
- BHC's page on the SEC website